A Collaborative Retrospective Study on the Efficacy and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: The European DME Registry Study.
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Rosenblatt A
- Cunha-Vaz J
- Sivaprasad S
- Bandello F
- Lanzetta P
- Kodjikian L
- Goldstein M
- Habot-Wilner Z
- Loewenstein A
- ARTES Study Group
Grupos
Abstract
To evaluate the efficacy, effect profile, and safety of dexamethasone implant on diabetic macular edema (DME) in a real-life setting, further comparing results by DME duration, previous treatment status, and diabetic control.
Datos de la publicación
- ISSN/ISSNe:
- 0161-6420, 1549-4713
- Tipo:
- Article
- Páginas:
- 377-393
- PubMed:
- 31932090
- Factor de Impacto:
- 5,028 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
OPHTHALMOLOGY ELSEVIER SCIENCE INC
Citas Recibidas en Web of Science: 51
Documentos
- No hay documentos
Filiaciones
Keywords
- GROWTH-FACTOR THERAPY; REAL-LIFE; PROTOCOL I; ASSOCIATION; PROGRESSION; LASER
Cita
Rosenblatt A,UDAONDO P,Cunha J,Sivaprasad S,Bandello F,Lanzetta P,Kodjikian L,Goldstein M,Habot Z,Loewenstein A,ARTES G. A Collaborative Retrospective Study on the Efficacy and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: The European DME Registry Study. Ophthalmology. 2020. 127. (3):p. 377-393. IF:12,079. (1).
Portal de investigación